Skip to main content

Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.

Publication ,  Journal Article
Greene, SJ; Butler, J
Published in: Circulation
January 8, 2019

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

January 8, 2019

Volume

139

Issue

2

Start / End Page

152 / 154

Location

United States

Related Subject Headings

  • Sodium-Glucose Transporter 2 Inhibitors
  • Risk Factors
  • Risk Assessment
  • Protective Factors
  • Primary Prevention
  • Practice Guidelines as Topic
  • Humans
  • Heart Failure
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Greene, S. J., & Butler, J. (2019). Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus. Circulation, 139(2), 152–154. https://doi.org/10.1161/CIRCULATIONAHA.118.037599
Greene, Stephen J., and Javed Butler. “Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.Circulation 139, no. 2 (January 8, 2019): 152–54. https://doi.org/10.1161/CIRCULATIONAHA.118.037599.
Greene SJ, Butler J. Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus. Circulation. 2019 Jan 8;139(2):152–4.
Greene, Stephen J., and Javed Butler. “Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus.Circulation, vol. 139, no. 2, Jan. 2019, pp. 152–54. Pubmed, doi:10.1161/CIRCULATIONAHA.118.037599.
Greene SJ, Butler J. Primary Prevention of Heart Failure in Patients With Type 2 Diabetes Mellitus. Circulation. 2019 Jan 8;139(2):152–154.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

January 8, 2019

Volume

139

Issue

2

Start / End Page

152 / 154

Location

United States

Related Subject Headings

  • Sodium-Glucose Transporter 2 Inhibitors
  • Risk Factors
  • Risk Assessment
  • Protective Factors
  • Primary Prevention
  • Practice Guidelines as Topic
  • Humans
  • Heart Failure
  • Diabetes Mellitus, Type 2
  • Cardiovascular System & Hematology